Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue 1.4 Market Analysis by Type 1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 CLIA Method 1.4.3 ELISA Method 1.5 Market by Application 1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026 1.5.2 Screening 1.5.3 Post-treatment Monitoring 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Prostate-specific Antigen (PSA) Testing Market Perspective (2015-2026) 2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions 2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2015-2020) 2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Prostate-specific Antigen (PSA) Testing Market Growth Strategy 2.3.6 Primary Interviews with Key Prostate-specific Antigen (PSA) Testing Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Market Size 3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2015-2020) 3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2015-2020) 3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio 3.2.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2019 3.3 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served 3.4 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service 3.5 Date of Enter into Prostate-specific Antigen (PSA) Testing Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2015-2020) 4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2021-2026) 5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application (2015-2026) 5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 6.2 Prostate-specific Antigen (PSA) Testing Key Players in North America (2019-2020) 6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 7 Europe 7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 7.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe (2019-2020) 7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 8 China 8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 8.2 Prostate-specific Antigen (PSA) Testing Key Players in China (2019-2020) 8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 8.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 9 Japan 9.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 9.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan (2019-2020) 9.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 9.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 10.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 10.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 11 India 11.1 India Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 11.2 Prostate-specific Antigen (PSA) Testing Key Players in India (2019-2020) 11.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 11.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020) 12.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America (2019-2020) 12.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) 12.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Abbott 13.1.1 Abbott Company Details 13.1.2 Abbott Business Overview and Its Total Revenue 13.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction 13.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)) 13.1.5 Abbott Recent Development 13.2 Boston Scientific Corporation 13.2.1 Boston Scientific Corporation Company Details 13.2.2 Boston Scientific Corporation Business Overview and Its Total Revenue 13.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction 13.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.2.5 Boston Scientific Corporation Recent Development 13.3 Bayer AG 13.3.1 Bayer AG Company Details 13.3.2 Bayer AG Business Overview and Its Total Revenue 13.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction 13.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.3.5 Bayer AG Recent Development 13.4 Siemens Healthcare 13.4.1 Siemens Healthcare Company Details 13.4.2 Siemens Healthcare Business Overview and Its Total Revenue 13.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction 13.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.4.5 Siemens Healthcare Recent Development 13.5 DiaSorin 13.5.1 DiaSorin Company Details 13.5.2 DiaSorin Business Overview and Its Total Revenue 13.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction 13.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.5.5 DiaSorin Recent Development 13.6 Roche 13.6.1 Roche Company Details 13.6.2 Roche Business Overview and Its Total Revenue 13.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction 13.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.6.5 Roche Recent Development 13.7 Beckman Coulter 13.7.1 Beckman Coulter Company Details 13.7.2 Beckman Coulter Business Overview and Its Total Revenue 13.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction 13.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.7.5 Beckman Coulter Recent Development 13.8 PerkinElmer 13.8.1 PerkinElmer Company Details 13.8.2 PerkinElmer Business Overview and Its Total Revenue 13.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction 13.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.8.5 PerkinElmer Recent Development 13.9 Tosoh 13.9.1 Tosoh Company Details 13.9.2 Tosoh Business Overview and Its Total Revenue 13.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction 13.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.9.5 Tosoh Recent Development 13.10 Ortho Clinical 13.10.1 Ortho Clinical Company Details 13.10.2 Ortho Clinical Business Overview and Its Total Revenue 13.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction 13.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 13.10.5 Ortho Clinical Recent Development 13.11 Fujirebio 10.11.1 Fujirebio Company Details 10.11.2 Fujirebio Business Overview and Its Total Revenue 10.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction 10.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.11.5 Fujirebio Recent Development 13.12 Mediwatch 10.12.1 Mediwatch Company Details 10.12.2 Mediwatch Business Overview and Its Total Revenue 10.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction 10.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.12.5 Mediwatch Recent Development 13.13 BodiTech 10.13.1 BodiTech Company Details 10.13.2 BodiTech Business Overview and Its Total Revenue 10.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction 10.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.13.5 BodiTech Recent Development 13.14 Bristol-Myers Squibb Company 10.14.1 Bristol-Myers Squibb Company Company Details 10.14.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 10.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction 10.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.14.5 Bristol-Myers Squibb Company Recent Development 13.15 GE Healthcare 10.15.1 GE Healthcare Company Details 10.15.2 GE Healthcare Business Overview and Its Total Revenue 10.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction 10.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.15.5 GE Healthcare Recent Development 13.16 Endocare 10.16.1 Endocare Company Details 10.16.2 Endocare Business Overview and Its Total Revenue 10.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction 10.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.16.5 Endocare Recent Development 13.17 Merck＆Co. 10.17.1 Merck＆Co. Company Details 10.17.2 Merck＆Co. Business Overview and Its Total Revenue 10.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction 10.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.17.5 Merck＆Co. Recent Development 13.18 Medtronic 10.18.1 Medtronic Company Details 10.18.2 Medtronic Business Overview and Its Total Revenue 10.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction 10.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.18.5 Medtronic Recent Development 13.19 Sanofi-Aventis SA 10.19.1 Sanofi-Aventis SA Company Details 10.19.2 Sanofi-Aventis SA Business Overview and Its Total Revenue 10.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction 10.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) 10.19.5 Sanofi-Aventis SA Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Prostate-specific Antigen (PSA) Testing Key Market Segments Table 2. Key Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue Table 3. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of CLIA Method Table 6. Key Players of ELISA Method Table 7. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2015-2020) Table 11. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Prostate-specific Antigen (PSA) Testing Market Growth Strategy Table 17. Main Points Interviewed from Key Prostate-specific Antigen (PSA) Testing Players Table 18. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2015-2020) (Million US$) Table 19. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2015-2020) Table 20. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019) Table 21. Global Prostate-specific Antigen (PSA) Testing by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service Table 24. Date of Enter into Prostate-specific Antigen (PSA) Testing Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2015-2020) Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2021-2026) Table 29. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2015-2020) Table 30. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 31. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2021-2026) Table 32. North America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 33. North America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 35. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 37. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 38. Europe Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 43. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 44. China Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 45. China Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 46. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 47. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 48. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 49. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 50. Japan Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 52. Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 53. Japan Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 54. Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 55. Japan Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 58. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 60. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 62. India Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 63. India Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 64. India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 65. India Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 66. India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 67. India Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 68. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020) Table 70. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020) Table 72. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020) Table 74. Abbott Company Details Table 75. Abbott Business Overview Table 76. Abbott Product Table 77. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 78. Abbott Recent Development Table 79. Boston Scientific Corporation Company Details Table 80. Boston Scientific Corporation Business Overview Table 81. Boston Scientific Corporation Product Table 82. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 83. Boston Scientific Corporation Recent Development Table 84. Bayer AG Company Details Table 85. Bayer AG Business Overview Table 86. Bayer AG Product Table 87. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 88. Bayer AG Recent Development Table 89. Siemens Healthcare Company Details Table 90. Siemens Healthcare Business Overview Table 91. Siemens Healthcare Product Table 92. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 93. Siemens Healthcare Recent Development Table 94. DiaSorin Company Details Table 95. DiaSorin Business Overview Table 96. DiaSorin Product Table 97. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 98. DiaSorin Recent Development Table 99. Roche Company Details Table 100. Roche Business Overview Table 101. Roche Product Table 102. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 103. Roche Recent Development Table 104. Beckman Coulter Company Details Table 105. Beckman Coulter Business Overview Table 106. Beckman Coulter Product Table 107. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 108. Beckman Coulter Recent Development Table 109. PerkinElmer Business Overview Table 110. PerkinElmer Product Table 111. PerkinElmer Company Details Table 112. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 113. PerkinElmer Recent Development Table 114. Tosoh Company Details Table 115. Tosoh Business Overview Table 116. Tosoh Product Table 117. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 118. Tosoh Recent Development Table 119. Ortho Clinical Company Details Table 120. Ortho Clinical Business Overview Table 121. Ortho Clinical Product Table 122. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 123. Ortho Clinical Recent Development Table 124. Fujirebio Company Details Table 125. Fujirebio Business Overview Table 126. Fujirebio Product Table 127. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 128. Fujirebio Recent Development Table 129. Mediwatch Company Details Table 130. Mediwatch Business Overview Table 131. Mediwatch Product Table 132. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 133. Mediwatch Recent Development Table 134. BodiTech Company Details Table 135. BodiTech Business Overview Table 136. BodiTech Product Table 137. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 138. BodiTech Recent Development Table 139. Bristol-Myers Squibb Company Company Details Table 140. Bristol-Myers Squibb Company Business Overview Table 141. Bristol-Myers Squibb Company Product Table 142. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 143. Bristol-Myers Squibb Company Recent Development Table 144. GE Healthcare Company Details Table 145. GE Healthcare Business Overview Table 146. GE Healthcare Product Table 147. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 148. GE Healthcare Recent Development Table 149. Endocare Company Details Table 150. Endocare Business Overview Table 151. Endocare Product Table 152. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 153. Endocare Recent Development Table 154. Merck＆Co. Company Details Table 155. Merck＆Co. Business Overview Table 156. Merck＆Co. Product Table 157. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 158. Merck＆Co. Recent Development Table 159. Medtronic Company Details Table 160. Medtronic Business Overview Table 161. Medtronic Product Table 162. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 163. Medtronic Recent Development Table 164. Sanofi-Aventis SA Company Details Table 165. Sanofi-Aventis SA Business Overview Table 166. Sanofi-Aventis SA Product Table 167. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$) Table 168. Sanofi-Aventis SA Recent Development Table 169. Research Programs/Design for This Report Table 170. Key Data Information from Secondary Sources Table 171. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2020 VS 2026 Figure 2. CLIA Method Features Figure 3. ELISA Method Features Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026 Figure 5. Screening Case Studies Figure 6. Post-treatment Monitoring Case Studies Figure 7. Other Case Studies Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions: 2020 VS 2026 Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2019 Figure 14. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2019 Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 25. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 27. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 29. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 31. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 33. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 35. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 37. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 39. Tosoh Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 41. Ortho Clinical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 43. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 45. Mediwatch Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 47. BodiTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 49. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 51. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 53. Endocare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 55. Merck＆Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 57. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 59. Sanofi-Aventis SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Abbott Boston Scientific Corporation Bayer AG Siemens Healthcare DiaSorin Roche Beckman Coulter PerkinElmer Tosoh Ortho Clinical Fujirebio Mediwatch BodiTech Bristol-Myers Squibb Company GE Healthcare Endocare Merck＆Co. Medtronic Sanofi-Aventis SA